Scientists found a natural defense against protein buildup, opening a new path to preventive treatments.

The Claude maker's 5% share pledge, worth $48bn, is a bid to win over regulators and investors before its stock market listing.

New research links a modest daily walk to less tau buildup and nearly half the cognitive and functional decline, even for those with early signs.

The Atlassian cofounder is rolling out a protocol that makes AI agents visible, governed team members, and keeps accountability with the human user.

Tech leaders want the shares given directly to Americans, not parked in a foundation.

The AI company is locking a slice of its value to social causes before a potential November IPO, with roughly 20% of shares now pledged to the public good.

The YouTube-native studio is expanding beyond platform revenue with a four-acre LA campus and partnerships with Disney and Fox. Here's what it means for media executives.

Official data shows Beijing's Treasury holdings at an 18-year low, but custodial shifts suggest the real number is far higher - and Canada is the tell.

A study of 100-plus European pollen records shows human abandonment of medieval farmland cut plant diversity by 40%, then restoration came from renewed human activity.

Woodside's Scarborough gas project is frozen mid-start-up after activists boarded the platform, a disruption with cost and reputational ripple effects for LNG operators.

Dodgy TV sticks and illegal streams are eating into sports' most valuable asset: live broadcast rights. Here's what the industry's response is up against.

A portable, electricity-free diagnostic could transform emergency care in ambulances, disaster zones, and remote clinics where lab machines are out of reach.